Daré Bioscience, Inc. (DARE) News
Track canonical SquawkNews coverage tagged to DARE, Daré Bioscience, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Daré Bioscience prices $6.0M registered direct offering
Daré Bioscience (DARE) announces the pricing of a $6.0 million registered direct offering priced at-the-market under Nasdaq rules.
EQUITY | Aug 14, 2026, 04:45 PM UTC
L
Daré Bioscience reports Q2 2026 results and commercial inflection
Daré Bioscience reports its second quarter 2026 results and highlights a commercial inflection as its multi-product women’s health strategy advances, according to TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 08:01 PM UTC
L
DARE - Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026 - Cli
DARE - Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026
EARNINGS | Aug 06, 2026, 01:05 PM UTC
L
DARE Launches Flora Sync
Dare Bioscience CEO discusses upcoming launch of Flora Sync LF5 in virtual investor segment, highlighting revenue opportunity
EARNINGS | Jun 25, 2026, 01:05 PM UTC